← Leaderboards
Damian Winston Young
Massachusetts Institute Of Technology
$5,728,468
Attributed
$7,087,935
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $885.7K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,087,935 · 6
By mechanism
R01$2,153,344 · 1
P50$2,128,795 · 1
P01$1,950,333 · 1
T32$565,590 · 1
P20$289,873 · 2
Top collaborators
- Nicolas L Young5 shared
- Xander H.T. Wehrens2 shared
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- David Michael Chenoweth$4,783,942
- Jeremy Kodanko$2,178,538
- Rick L Danheiser$2,850,597
- Stephen L Buchwald$33,018,686
- Matthew Webber$3,496,287
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsSmall MoleculeDrug DiscoveryHigh Throughput ScreeningProteinsSamplingTechnologyInnovationBaseLibrariesMethodologyPathway InteractionsCollectionDesignMalignant NeoplasmsAreaStructureIn VivoRegulationBiologicalBindingCellsDrug CandidatePharmacology
Grant awards (21)
Cardiovascular Research and Drug Development (CRDD) training program$278,622
T32 · FY2025 · HL
Neutron encoded activity based probes$423,814
R01 · FY2024 · GM
Cardiovascular Research and Drug Development (CRDD) training program$286,968
T32 · FY2024 · HL
Neutron encoded activity based probes$429,526
R01 · FY2023 · GM
Neutron encoded activity based probes$429,526
R01 · FY2022 · GM
Neutron encoded activity based probes$430,478
R01 · FY2021 · GM
DNA-Encoded Chemistry Technology (DEC-Tec) Core$383,801
P01 · FY2021 · HD · contact PI
Neutron encoded activity based probes$440,000
R01 · FY2020 · GM
DNA-Encoded Chemistry Technology (DEC-Tec) Core$391,633
P01 · FY2020 · HD · contact PI
DNA-Encoded Chemistry Technology (DEC-Tec) Core$391,633
P01 · FY2019 · HD · contact PI
Discovery of UHRF1 inhibitors in the treatment of hepatocellular carcinoma$97,290
P20 · FY2019 · CA · contact PI
Discovery of UHRF1 inhibitors in the treatment of hepatocellular carcinoma$45,439
P20 · FY2019 · CA · contact PI
DNA-Encoded Chemistry Technology (DEC-Tec) Core$391,633
P01 · FY2018 · HD · contact PI
Discovery of UHRF1 inhibitors in the treatment of hepatocellular carcinoma$100,300
P20 · FY2018 · CA · contact PI
Discovery of UHRF1 inhibitors in the treatment of hepatocellular carcinoma$46,844
P20 · FY2018 · CA · contact PI
DNA-Encoded Chemistry Technology (DEC-Tec) Core$391,633
P01 · FY2017 · HD · contact PI
Coordinating CMLD methodology with the build/couple/pair strategy to yield comple$406,932
P50 · FY2011 · GM · contact PI
Coordinating CMLD methodology with the build/couple/pair strategy to yield comple$411,144
P50 · FY2010 · GM · contact PI
Coordinating CMLD methodology with the build/couple/pair strategy to yield comple$425,041
P50 · FY2009 · GM · contact PI
Coordinating CMLD methodology with the build/couple/pair strategy to yield comple$455,251
P50 · FY2008 · GM · contact PI
Coordinating CMLD methodology with the build/couple/pair strategy to yield comple$430,427
P50 · FY2008 · GM · contact PI